Treatment of HBeAg negative chronic hepatitis B with new drugs (adefovir and others)

被引:9
作者
Hadziyannis, SJ
Papatheodoridis, GV
机构
[1] Henry Dunant Hosp, Dept Med & Hepatol, Athens, Greece
[2] Hippokrateion Hosp, Acad Dept Med, Athens, Greece
关键词
D O I
10.1016/S0168-8278(03)00334-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S172 / S176
页数:5
相关论文
共 47 条
[1]
Ahmad J, 2000, HEPATOLOGY, V32, p292A
[2]
Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription [J].
Arts, EJ ;
Wainberg, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :527-540
[3]
Treatment of HBeAg-negative chronic hepatitis B with interferon or pegylated interferon [J].
Brunetto, MR ;
Oliveri, F ;
Colombatto, P ;
Coco, B ;
Ciccorossi, P ;
Bonino, F .
JOURNAL OF HEPATOLOGY, 2003, 39 :S164-S167
[4]
Antiviral L-nucleosides specific for hepatitis B virus infection [J].
Bryant, ML ;
Bridges, EG ;
Placidi, L ;
Faraj, A ;
Loi, AG ;
Pierra, C ;
Dukhan, D ;
Gosselin, G ;
Imbach, JL ;
Hernandez, B ;
Juodawlkis, A ;
Tennant, B ;
Korba, B ;
Cote, P ;
Marion, P ;
Cretton-Scott, E ;
Schinazi, RF ;
Sommadossi, JP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :229-235
[5]
Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir [J].
Cundy, KC .
CLINICAL PHARMACOKINETICS, 1999, 36 (02) :127-143
[6]
de Man R, 2000, HEPATOLOGY, V32, p376A
[7]
The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: A randomized, double-blind, placebo-controlled trial [J].
Deeks, SG ;
Collier, A ;
Lalezari, J ;
Pavia, A ;
Rodrigue, D ;
Drew, WL ;
Toole, J ;
Jaffe, HS ;
Mulato, AS ;
Lamy, PD ;
Li, WX ;
Cherrington, JM ;
Hellmann, N ;
Kahn, J .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (06) :1517-1523
[8]
Lamivudine-resistant HBV is cross-resistant to L-dT and L-dC in vitro [J].
Delaney, W ;
Yang, HL ;
Miller, M ;
Gibbs, C ;
Xiong, S .
JOURNAL OF HEPATOLOGY, 2002, 36 :89-89
[9]
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B [J].
Hadziyannis, SJ ;
Tassopoulos, NC ;
Heathcote, EJ ;
Chang, TT ;
Kitis, G ;
Rizzetto, M ;
Marcellin, P ;
Lim, SG ;
Goodman, Z ;
Wulfsohn, MS ;
Xiong, S ;
Fry, J ;
Brosgart, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) :800-807
[10]
T-cell mediated immune responses in patients with hepatitis B e antigen negative chronic hepatitis B. [J].
Vassilopoulos, D ;
Rapti, I ;
Nikolaou, M ;
Hadziyannis, SJ .
HEPATOLOGY, 2001, 34 (04) :315A-315A